Delivery Order SPE2DB20D3101-SPE2DB25FRUH4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,315.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram units. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The point of performance is located at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Estrace 0.01% Cream in 42.5-gram units, with a ceiling value of $2,357.79 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on July 22, 2025, with a ceiling value of $1,150.32 and an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Estrace 0.01% Cream in a 42.5-gram quantity. This firm fixed-price delivery order, valued at $5,201.20, represents a non-competitive set-aside procurement and is scheduled for completion by July 23, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estradiol 0.01% cream, a specialty pharmaceutical product, with a ceiling value of $1,555.58 and a completion date of October 30, 2024. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen is the prime...
- The Defense Logistics Agency awarded a $2,815.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562259807 Estradiol 0.01% cream in 42.5 gram quantities. The place of performance for this single-day contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. As the DLA is responsible for procuring medical supplies and pharmaceuticals for various Department of Defense programs and initiatives, this delivery order was likely placed to...
- The Defense Logistics Agency awarded a delivery order valued at $1,418.19 to AmerisourceBergen Drug Corp for Estrace 0.01% cream (42.5 grams) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's status as a child contract under the company's broader Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Estradiol 0.01% cream in a 42.5 gram size. The firm-fixed-price contract has a ceiling value of $2,978.04 and is set to expire on September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this order as a part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,221.14 on August 25, 2025, for the supply of Estradiol 0.06% 1.25G Gel Pump in 37.5GM quantity. The contract is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the company's...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUH4Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a broad range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company has an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency's Medical Supply Chain, covering everything from specialty medications and vaccines to medical devices. This particular delivery order for hormone treatment medication supports the Defense Health Agency and other government healthcare systems through the flexible contracting framework established under AmerisourceBergen's prime indefinite delivery vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/3/25 |